SPIMACO Pharmaceutical Company announced today on tadawul signing 5 years renewable agreement with SANOFI to manufacture and distribute the Doanil M Diabetes medication.
Doanil M is to be manufactured in SPIMACO’s medical plant in Qassim and to be distributed by ARAC (a wholly owned sub of SPIMACO).
Comments
{{DisplayName}}
{{ElapsedTime}}